Edwards Lifesciences Gross Profit 2010-2024 | EW

Edwards Lifesciences annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Edwards Lifesciences gross profit for the quarter ending September 30, 2024 was $1.092B, a 9.94% increase year-over-year.
  • Edwards Lifesciences gross profit for the twelve months ending September 30, 2024 was $4.868B, a 14.49% increase year-over-year.
  • Edwards Lifesciences annual gross profit for 2023 was $4.625B, a 7.51% increase from 2022.
  • Edwards Lifesciences annual gross profit for 2022 was $4.302B, a 7.99% increase from 2021.
  • Edwards Lifesciences annual gross profit for 2021 was $3.984B, a 20.51% increase from 2020.
Edwards Lifesciences Annual Gross Profit
(Millions of US $)
2023 $4,625
2022 $4,302
2021 $3,984
2020 $3,306
2019 $3,234
2018 $2,783
2017 $2,560
2016 $2,166
2015 $1,877
2014 $1,697
2013 $1,529
2012 $1,409
2011 $1,189
2010 $1,039
2009 $922
Edwards Lifesciences Quarterly Gross Profit
(Millions of US $)
2024-09-30 $1,092
2024-06-30 $1,101
2024-03-31 $1,213
2023-12-31 $1,464
2023-09-30 $993
2023-06-30 $1,039
2023-03-31 $1,130
2022-12-31 $1,090
2022-09-30 $1,065
2022-06-30 $1,105
2022-03-31 $1,042
2021-12-31 $1,020
2021-09-30 $999
2021-06-30 $1,042
2021-03-31 $923
2020-12-31 $895
2020-09-30 $860
2020-06-30 $687
2020-03-31 $864
2019-12-31 $888
2019-09-30 $802
2019-06-30 $783
2019-03-31 $761
2018-12-31 $743
2018-09-30 $682
2018-06-30 $698
2018-03-31 $661
2017-12-31 $653
2017-09-30 $608
2017-06-30 $631
2017-03-31 $668
2016-12-31 $555
2016-09-30 $538
2016-06-30 $557
2016-03-31 $517
2015-12-31 $495
2015-09-30 $469
2015-06-30 $458
2015-03-31 $454
2014-12-31 $458
2014-09-30 $439
2014-06-30 $424
2014-03-31 $377
2013-12-31 $392
2013-09-30 $367
2013-06-30 $394
2013-03-31 $376
2012-12-31 $388
2012-09-30 $336
2012-06-30 $352
2012-03-31 $332
2011-12-31 $311
2011-09-30 $287
2011-06-30 $303
2011-03-31 $288
2010-12-31 $279
2010-09-30 $253
2010-06-30 $265
2010-03-31 $242
2009-12-31 $245
2009-09-30 $227
2009-06-30 $234
2009-03-31 $217
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.082B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.584B 24.71
Intuitive Surgical (ISRG) United States $193.049B 100.93
Alcon (ALC) Switzerland $43.825B 29.32
IQVIA Holdings (IQV) United States $36.452B 20.08
IDEXX Laboratories (IDXX) United States $34.535B 40.67
DexCom (DXCM) United States $30.463B 45.88
Waters (WAT) United States $22.843B 33.78
STERIS (STE) Ireland $21.623B 24.89
SONOVA HOLDING (SONVY) Switzerland $20.352B 0.00
Hologic (HOLX) United States $18.042B 19.49
Sysmex ADR (SSMXY) Japan $13.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.922B 13.27
Globus Medical (GMED) United States $11.657B 29.52
Penumbra (PEN) United States $9.369B 91.77
Masimo (MASI) United States $9.238B 44.70
Teleflex (TFX) United States $8.957B 14.28
Glaukos (GKOS) United States $7.920B 0.00
PROCEPT BioRobotics (PRCT) United States $4.988B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.329B 99.88
Inari Medical (NARI) United States $3.040B 0.00
TransMedics (TMDX) United States $2.910B 92.25
LivaNova (LIVN) United Kingdom $2.851B 16.46
Nihon Kohden (NHNKY) Japan $2.276B 17.29
Elekta AB (EKTAY) Sweden $2.261B 20.33
Tandem Diabetes Care (TNDM) United States $2.012B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.889B 0.00
Alphatec Holdings (ATEC) United States $1.486B 0.00
Pulse Biosciences (PLSE) United States $1.316B 0.00
Artivion (AORT) United States $1.237B 82.00
OPKO Health (OPK) United States $1.051B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.881B 14.97
Paragon 28 (FNA) United States $0.863B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.746B 0.00
IRadimed (IRMD) United States $0.683B 36.94
Mesa Laboratories (MLAB) United States $0.636B 15.00
OrthoPediatrics (KIDS) United States $0.629B 0.00
AxoGen (AXGN) United States $0.612B 0.00
SiBone (SIBN) United States $0.569B 0.00
Treace Medical Concepts (TMCI) United States $0.531B 0.00
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Semler Scientific (SMLR) United States $0.473B 27.82
Tactile Systems Technology (TCMD) United States $0.469B 25.38
Delcath Systems (DCTH) United States $0.380B 0.00
CVRx (CVRX) United States $0.372B 0.00
ClearPoint Neuro (CLPT) United States $0.341B 0.00
NeuroPace (NPCE) United States $0.316B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
Inogen (INGN) United States $0.231B 0.00
Accuray (ARAY) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.172B 0.00
Atossa Genetics (ATOS) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.93
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.031B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Neuronetics (STIM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.015B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00